Trials / Completed
CompletedNCT04867551
A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
A Phase II Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Objective of this study is to investigate the safety, pharmacokinetics and efficacy of KDT-3594 in patients with early Parkinson's disease without a concomitant medication of L-dopa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KDT-3594 | oral administration, dose titration |
Timeline
- Start date
- 2021-05-15
- Primary completion
- 2021-09-06
- Completion
- 2021-09-06
- First posted
- 2021-04-30
- Last updated
- 2022-05-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04867551. Inclusion in this directory is not an endorsement.